DURECT beats by $0.02, beats on revenues

DURECT (DRRX): Q1 EPS of -$0.03 beats by $0.02.

Revenue of $6.3M beats by $2.18M.

From other sites
Comments (1)
  • vit777
    , contributor
    Comments (6) | Send Message
    Great news. Hope POSIDUR will be approved sooner or later
    1 May 2014, 07:09 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs